Home | Welcome to Contract Pharma   
Last Updated Friday, May 22 2015

Print

Breaking News

March 26, 2015
Yordon retires, Kung to serve as chairman  Read More »
March 26, 2015
Expands safety management solutions   Read More »
March 26, 2015
Combined service offering aims to speed drug development and reduce costs  Read More »
March 25, 2015
Will evaluate the safety, tolerability and pharmacokinetics in advanced liver cancer  Read More »
March 25, 2015
Will receive as much as £652,000 to expand bioproduction research  Read More »
March 25, 2015
Triggers $7 million BARDA milestone  Read More »
March 24, 2015
Establishes U.S. subsidiary in Boston.  Read More »
March 24, 2015
Sponsors and CRO strategic partners drive RTP expansion.   Read More »
March 24, 2015
Bangalore oral solids manufacturing facility complied with all FDA requirements  Read More »
March 23, 2015
Mazzola brings 25 years of experience  Read More »
March 23, 2015
To develop Confluence’s lead candidate for Fragile X Syndrome  Read More »
March 23, 2015
Wright responsible for identifying new sources of innovation and growth  Read More »
March 23, 2015
To develop targeted anticancer therapeutics for as many as two undisclosed targets  Read More »
March 23, 2015
Introduces new corporate identity and logo  Read More »
March 23, 2015
Adds 2,050 sq. ft. of cleanroom suites with dedicated air handling for potent compounds  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On